• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素的作用机制及其对结缔组织的影响。

Mechanisms of action of cyclosporine and effects on connective tissues.

作者信息

Russell G, Graveley R, Seid J, al-Humidan A K, Skjodt H

机构信息

Department of Human Metabolism and Clinical Biochemistry, University of Sheffield Medical School, England.

出版信息

Semin Arthritis Rheum. 1992 Jun;21(6 Suppl 3):16-22. doi: 10.1016/0049-0172(92)90009-3.

DOI:10.1016/0049-0172(92)90009-3
PMID:1502562
Abstract

Cyclosporine is a potent immunomodulatory agent with an increasing number of clinical applications. Its major mode of action is inhibition of the production of cytokines involved in the regulation of T-cell activation. In particular, cyclosporine inhibits the transcription of interleukin 2. Although cyclosporine's major actions are on T cells, there is some evidence that it produces direct effects on other cell types. Its immunosuppressive action is closely linked to its binding of cyclophilin, a member of a family of high-affinity cyclosporine-binding proteins widely distributed in different cell types and in different species. The cyclophilins have been shown to have peptidyl-prolyl cis-trans isomerase enzyme activity that is blocked by cyclosporine. Although this may be a factor in cyclosporine's selective inhibition of cytokine gene transcription, it is still unclear whether inhibition of this activity is the mechanism through which cyclosporine exerts its effects on target cells. The ubiquitous presence of cyclophilins raises the question of why cyclosporine has major effects on T cells. Perhaps the critical proteins affected are transcriptional regulators restricted in their tissue distribution. The effects of cyclosporine on T cells and, directly or indirectly, on connective tissue cells, all of which can produce a range of cytokines, are of interest in relation to the tissue changes that occur in such inflammatory conditions as rheumatoid arthritis.

摘要

环孢素是一种具有越来越多临床应用的强效免疫调节剂。其主要作用方式是抑制参与调节T细胞活化的细胞因子的产生。特别是,环孢素抑制白细胞介素2的转录。虽然环孢素的主要作用是作用于T细胞,但有一些证据表明它对其他细胞类型有直接影响。其免疫抑制作用与其与亲环蛋白的结合密切相关,亲环蛋白是一类高亲和力环孢素结合蛋白家族的成员,广泛分布于不同细胞类型和不同物种中。已证明亲环蛋白具有肽基脯氨酰顺反异构酶活性,该活性被环孢素阻断。虽然这可能是环孢素选择性抑制细胞因子基因转录的一个因素,但仍不清楚抑制这种活性是否是环孢素对靶细胞发挥作用的机制。亲环蛋白的普遍存在提出了一个问题,即为什么环孢素对T细胞有主要影响。也许受影响的关键蛋白质是组织分布受限的转录调节因子。环孢素对T细胞以及直接或间接对结缔组织细胞的影响,所有这些细胞都能产生一系列细胞因子,与类风湿性关节炎等炎症性疾病中发生的组织变化有关,因此备受关注。

相似文献

1
Mechanisms of action of cyclosporine and effects on connective tissues.环孢素的作用机制及其对结缔组织的影响。
Semin Arthritis Rheum. 1992 Jun;21(6 Suppl 3):16-22. doi: 10.1016/0049-0172(92)90009-3.
2
Cyclosporin A. Mode of action and effects on bone and joint tissues.环孢素A。作用机制及其对骨骼和关节组织的影响。
Scand J Rheumatol Suppl. 1992;95:9-18. doi: 10.3109/03009749209101478.
3
The effects of cyclosporin A on bone and cartilage.
Br J Rheumatol. 1993 Mar;32 Suppl 1:42-6.
4
Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.肽基脯氨酰顺反异构酶和钙调神经磷酸酶在环孢素A、FK506和雷帕霉素抗疟作用机制中的作用
Biochem Pharmacol. 1994 Aug 3;48(3):495-503. doi: 10.1016/0006-2952(94)90279-8.
5
Mechanism of action of cyclosporin in rheumatoid arthritis.环孢素在类风湿关节炎中的作用机制。
Clin Rheumatol. 1995 Sep;14 Suppl 2:22-5. doi: 10.1007/BF02215854.
6
Cyclosporin A produces distal renal tubular acidosis by blocking peptidyl prolyl cis-trans isomerase activity of cyclophilin.环孢素A通过阻断亲环蛋白的肽基脯氨酰顺反异构酶活性而产生远端肾小管性酸中毒。
Am J Physiol Renal Physiol. 2005 Jan;288(1):F40-7. doi: 10.1152/ajprenal.00218.2004. Epub 2004 Sep 7.
7
Cyclosporin A and its non-immunosuppressive derivative exhibit a differential effect on cell-mediated mineralization in culture.环孢素A及其非免疫抑制衍生物对培养物中细胞介导的矿化具有不同的作用。
J Cell Biochem. 1997 Feb;64(2):209-16.
8
Intracellular targets of cyclosporine.
J Am Acad Dermatol. 1990 Dec;23(6 Pt 2):1329-32; discussion 1332-4. doi: 10.1016/0190-9622(90)70361-k.
9
Cyclophilin-facilitated membrane translocation as pharmacological target to prevent intoxication of mammalian cells by binary clostridial actin ADP-ribosylated toxins.亲环素促进的膜易位作为预防二元梭状芽胞杆菌 actin ADP-ribosylated 毒素中毒的药理学靶点。
J Mol Biol. 2015 Mar 27;427(6 Pt A):1224-38. doi: 10.1016/j.jmb.2014.07.013. Epub 2014 Jul 21.
10
Extracellular cyclophilins in health and disease.健康与疾病中的细胞外亲环素
Biochim Biophys Acta. 2015 Oct;1850(10):2087-95. doi: 10.1016/j.bbagen.2014.11.013. Epub 2014 Nov 18.

引用本文的文献

1
Target the Heart: A New Axis of Alzheimer's Disease Prevention.靶向心脏:阿尔茨海默病预防的新轴
J Dement Alzheimers Dis. 2025 Jun;2(2). doi: 10.3390/jdad2020010. Epub 2025 May 1.
2
Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson's disease: Insights from non-human primate studies.帕金森病中使用异体与自体来源进行神经元细胞替代的优势与挑战:来自非人灵长类动物研究的见解
Brain Res Bull. 2025 May;224:111297. doi: 10.1016/j.brainresbull.2025.111297. Epub 2025 Mar 12.
3
Treatment with cyclosporine attenuates the inflammatory process and severity of bisphosphonate-induced osteonecrosis of the jaws in rats.
用环孢素治疗可减轻大鼠双膦酸盐诱导的颌骨坏死的炎症过程和严重程度。
Inflammopharmacology. 2025 Apr;33(4):2007-2022. doi: 10.1007/s10787-025-01673-6. Epub 2025 Feb 24.
4
Protein phosphatases in systemic autoimmunity.系统性自身免疫中的蛋白磷酸酶。
Immunometabolism (Cobham). 2025 Feb 10;7(1):e00056. doi: 10.1097/IN9.0000000000000056. eCollection 2025 Jan.
5
Lymph node targeting of cyclosporine ameliorates ocular manifestations in a mouse model of systemic lupus erythematosus (SLE) via PD-L1.环孢素的淋巴结靶向作用通过程序性死亡配体1(PD-L1)改善系统性红斑狼疮(SLE)小鼠模型的眼部表现。
Nano Today. 2024 Aug;57. doi: 10.1016/j.nantod.2024.102359. Epub 2024 Jun 15.
6
Basics and Art of Immunosuppression in Liver Transplantation.肝移植中的免疫抑制基础与艺术
J Clin Exp Hepatol. 2024 May-Jun;14(3):101345. doi: 10.1016/j.jceh.2024.101345. Epub 2024 Jan 24.
7
Recent progress of nanomedicine in managing dry eye disease.纳米医学在治疗干眼病方面的最新进展。
Adv Ophthalmol Pract Res. 2024 Jan 29;4(1):23-31. doi: 10.1016/j.aopr.2024.01.008. eCollection 2024 Feb-Mar.
8
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy.癌症治疗中纳米药物对肿瘤相关巨噬细胞的靶向作用
Pharmaceutics. 2023 Dec 29;16(1):61. doi: 10.3390/pharmaceutics16010061.
9
The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs.蛋白类和肽类药物的现行与有前景的口服递药方法。
Int J Mol Sci. 2024 Jan 9;25(2):815. doi: 10.3390/ijms25020815.
10
Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus.系统性红斑狼疮的当前治疗方法、新兴疗法及新展望
Life (Basel). 2023 Jul 1;13(7):1496. doi: 10.3390/life13071496.